Primary central nervous system erythroid sarcoma with NFIA-CBFA2T3 translocation: A rare but distinct clinicopathologic entity

Am J Hematol. 2020 Nov;95(11):E299-E301. doi: 10.1002/ajh.25944. Epub 2020 Aug 17.

Authors

Yevgeniy Linnik¹, Devang Pastakia², Ian Dryden³, David R Head¹, Emily F Mason¹

Affiliations

¹ Department of Pathology, Microbiology, and Immunology, Division of Hematopathology, Vanderbilt University Medical Center, Nashville, Tennessee.
² Department of Pediatrics, Division of Pediatric Hematology and Oncology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee.
³ Department of Pathology, Microbiology, and Immunology, Division of Neuropathology, Vanderbilt University Medical Center, Nashville, Tennessee.

PMID: 32697373
DOI: 10.1002/ajh.25944

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Brain Neoplasms* / diagnostic imaging
Brain Neoplasms* / genetics
Child, Preschool
Humans
Male
NFI Transcription Factors* / genetics
NFI Transcription Factors* / metabolism
Oncogene Proteins, Fusion* / genetics
Oncogene Proteins, Fusion* / metabolism
Repressor Proteins* / genetics
Repressor Proteins* / metabolism
Sarcoma* / diagnostic imaging
Sarcoma* / genetics
Sarcoma* / metabolism
Translocation, Genetic*

Substances

CBFA2T3 protein, human
NFI Transcription Factors
NFIA protein, human
Oncogene Proteins, Fusion
Repressor Proteins